Suchergebnisse - "Minassian, Angela M"

PubPharm (10)

1

Superior antibody immunogenicity of a viral-vectored RH5 blood-stage malaria vaccine in Tanzanian infants as compared to adults

enthalten in: Med (New York, N.Y.) | 2023

von Silk, S. | Kalinga, W. | Mtaka, I. | +31

2

Reactogenicity, immunogenicity and breakthrough infections following heterologous or fractional second dose COVID-19 vaccination in adolescents (Com-COV3) : A randomised controlled trial

enthalten in: The Journal of infection | 2023

von Kelly, E. | Greenland, M. | de Whalley, P. | +31

3

Persistence of immune responses after heterologous and homologous third COVID-19 vaccine dose schedules in the UK : eight-month analyses of the COV-BOOST trial

enthalten in: The Journal of infection | 2023

von Liu, X. | Munro, A. | Wright, A. | +59

4

Assessment of precision in growth inhibition assay (GIA) using human anti-PfRH5 antibodies

enthalten in: Malaria journal | 2023

von Miura, K. | Diouf, A. | Fay, M. | +7

5

Safety and Efficacy of the NVX-CoV2373 Coronavirus Disease 2019 Vaccine at Completion of the Placebo-Controlled Phase of a Randomized Controlled Trial

enthalten in: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America | 2023

von Heath, P. | Galiza, E. | Baxter, D. | +42

6

Safety, immunogenicity, and reactogenicity of BNT162b2 and mRNA-1273 COVID-19 vaccines given as fourth-dose boosters following two doses of ChAdOx1 nCoV-19 or BNT162b2 and a third dose of BNT162b2 (COV-BOOST) : a multicentre, blinded, phase 2, randomised trial

enthalten in: The Lancet. Infectious diseases | 2022

von Munro, A. | Feng, S. | Janani, L. | +153

CommentIn: Lancet Infect Dis. 2022 Aug;22(8):1092-1093. - PMID 35550263

7

Persistence of immunogenicity after seven COVID-19 vaccines given as third dose boosters following two doses of ChAdOx1 nCov-19 or BNT162b2 in the UK : Three month analyses of the COV-BOOST trial

enthalten in: The Journal of infection | 2022

von Liu, X. | Munro, A. | Feng, S. | +56

CommentIn: J Infect. 2023 Feb;86(2):154-225. - PMID 36509358

8

Correlates of protection against symptomatic and asymptomatic SARS-CoV-2 infection

enthalten in: Nature medicine | 2021

von Feng, S. | Phillips, D. | White, T. | +96

9

Safety and immunogenicity of the ChAdOx1 nCoV-19 (AZD1222) vaccine against SARS-CoV-2 in HIV infection : a single-arm substudy of a phase 2/3 clinical trial

enthalten in: The lancet. HIV | 2021

von Frater, J. | Ewer, K. | Ogbe, A. | +67

CommentIn: Lancet HIV. 2021 Aug;8(8):e455-e456. - PMID 34153265

10

Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2 : a preliminary report of a phase 1/2, single-blind, randomised controlled trial

enthalten in: Lancet (London, England) | 2020

von Folegatti, P. | Ewer, K. | Aley, P. | +130

CommentIn: Lancet Infect Dis. 2020 Jul;20(7):760-761. - PMID 32325036

1
[1]